Purpose Male breast cancer (BC) is rare, representing approximately 1% of cancers that
occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not …

Male breast cancer is a rare malignancy that accounts for less than 1% of all cancers in men
and less than 1% of all breast cancers. But the incidence is rising and in some patient …

Background The causes, optimal treatments, and medical/psychosocial sequelae of breast
cancer in men are poorly understood. Design A systematic review of the English language …

Purpose Genetic predisposition to male breast cancer (MBC) is not well understood. The
aim of this study was to better define the predisposition genes contributing to MBC and the …

Male breast cancer (MaleBC) is a rare disease, accounting for< 1% of all male tumors.
During the last few years, there has been an increase in the incidence of this disease, along …

Male breast cancer is a rare disease, accounting for only 1% of breast cancer diagnoses in
the USA. The current literature suggests that genetic factors including BRCA2 mutations …

At least 10% of ovarian tumors are hereditary and associated with highly penetrant,
autosomal, dominant genetic predisposition. Three clinical manifestations of hereditary …

Although similar phenotypically, there is evidence that male and female breast cancer differ
in their molecular landscapes. In this systematic review, we consolidated all existing …

Background and study design Male breast cancer (MBC) is a rare disease compared with
female BC and our current understanding regarding breast carcinogenesis in men has been …

Simple Summary The role of gender in oncology is an issue that is starting to be recognized
as being of extreme importance in the last few years. While breast cancer is commonly …